{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:58:16Z","timestamp":1793336296281,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81970471"],"award-info":[{"award-number":["81970471"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Health Popul Nutr"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>Gut microbiota might play a crucial role in the pathogenesis of irritable bowel syndrome (IBS), and probiotics supplement may be an effective treatment option. This study aims to explore the therapeutic effects of Golden bifid on the diarrhea-predominant IBS (IBS-D).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Twenty-one consecutive IBS-D patients were recruited based on Rome IV criteria. All patients took 2000\u00a0mg Golden bifid triple daily for 4\u00a0weeks. Gastrointestinal (GI) symptoms, psychological symptoms, small intestine bacterial overgrowth (SIBO) and fecal microbiota characteristics were evaluated in IBS-D patients before and after treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After 4-week treatment of Golden bifid, the GI symptoms such as abdominal pain (2.90\u2009\u00b1\u20091.04 vs. 1.90\u2009\u00b1\u20091.26, <jats:italic>P<\/jats:italic>\u2009=\u20090.002), abdominal distension (2.00\u2009\u00b1\u20091.34 vs. 1.29\u2009\u00b1\u20091.31, <jats:italic>P<\/jats:italic>\u2009=\u20090.007), diarrhea (3.24\u2009\u00b1\u20091.37 vs. 1.81\u2009\u00b1\u20091.21, <jats:italic>P<\/jats:italic>\u2009=\u20090.001), defecatory urgency (3.48\u2009\u00b1\u20091.03 vs. 2.33\u2009\u00b1\u20091.35, <jats:italic>P<\/jats:italic>\u2009=\u20090.000) and incomplete evacuation (2.71\u2009\u00b1\u20091.15 vs. 1.76\u2009\u00b1\u20091.26, <jats:italic>P<\/jats:italic>\u2009=\u20090.003) were significantly alleviated in IBS-D patients. The Self-Rating\u00a0Depression\u00a0Scale\u00a0(SDS) decreased significantly (46.19\u2009\u00b1\u200911.36 vs. 43.33\u2009\u00b1\u20099.65, <jats:italic>P<\/jats:italic>\u2009=\u20090.041), and SIBO could be eradicated in 25% (4\/16) of IBS-D patients with SIBO. Meanwhile, the abundance of <jats:italic>Unclassified Lachnospiraceae<\/jats:italic> and <jats:italic>Dorea<\/jats:italic> in genus level and <jats:italic>Unclassified Lachnospiraceae<\/jats:italic>, <jats:italic>Bacterium Dorea<\/jats:italic>, <jats:italic>Bacterium Butyricicoccus<\/jats:italic> and <jats:italic>Dorea formicigenerans ATCC 27755<\/jats:italic> in species level were increased in fecal microbiota (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Golden bifid could improve most of GI symptoms and depressive symptoms in IBS-D patients and eradicate a small proportion of SIBO in those IBS-D patients with SIBO. What's more, Golden bifid could also modulate the fecal microbiota in IBS-D patients, which implied that the Golden bifid might improve IBS-D via microbiota modulation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41043-022-00302-0","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T10:03:12Z","timestamp":1652695392000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Golden bifid might improve diarrhea-predominant irritable bowel syndrome via microbiota modulation"],"prefix":"10.1186","volume":"41","author":[{"given":"Mei","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Shou","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,16]]},"reference":[{"key":"302_CR1","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1111\/j.1365-2036.2004.01939.x","volume":"19","author":"LS Xiong","year":"2004","unstructured":"Xiong LS, Chen MH, Chen HX, Xu AG, Wang WA, Hu PJ. A population-based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling. Aliment Pharmacol Ther. 2004;19:1217\u201324.","journal-title":"Aliment Pharmacol Ther"},{"key":"302_CR2","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1136\/gutjnl-2015-311240","volume":"66","author":"AD Sperber","year":"2017","unstructured":"Sperber AD, Dumitrascu D, Fukudo S, et al. The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review. Gut. 2017;66:1075\u201382.","journal-title":"Gut"},{"key":"302_CR3","first-page":"969","volume":"53","author":"L Zhang","year":"2014","unstructured":"Zhang L, Duan L, Liu Y, et al. A meta-analysis of the prevalence and risk factors of irritable bowel syndrome in Chinese community. Zhonghua Nei Ke Za Zhi. 2014;53:969\u201375.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"302_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.4040\/jkan.2013.43.5.579","volume":"43","author":"M Heitkemper","year":"2013","unstructured":"Heitkemper M, Jarrett M, Jun SE. Update on irritable bowel syndrome program of research. J Korean Acad Nurs. 2013;43:579\u201386.","journal-title":"J Korean Acad Nurs"},{"key":"302_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/MOG.0b013e32835a3493","volume":"29","author":"F Shanahan","year":"2013","unstructured":"Shanahan F. The colonic microbiota in health and disease. Curr Opin Gastroenterol. 2013;29:49\u201354.","journal-title":"Curr Opin Gastroenterol"},{"key":"302_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/imr.12567","volume":"279","author":"JM Pickard","year":"2017","unstructured":"Pickard JM, Zeng MY, Caruso R, N\u00fa\u00f1ez G. Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease. Immunol Rev. 2017;279:70\u201389.","journal-title":"Immunol Rev"},{"key":"302_CR7","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/nmo.12315","volume":"26","author":"T Piche","year":"2014","unstructured":"Piche T. Tight junctions and IBS\u2013the link between epithelial permeability, low-grade inflammation, and symptom generation? Neurogastroenterol Motil. 2014;26:296\u2013302.","journal-title":"Neurogastroenterol Motil"},{"key":"302_CR8","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1053\/j.gastro.2014.02.037","volume":"146","author":"EA Mayer","year":"2014","unstructured":"Mayer EA, Savidge T, Shulman RJ. Brain\u2013gut microbiome interactions and functional bowel disorders. Gastroenterology. 2014;146:1500\u201312.","journal-title":"Gastroenterology"},{"key":"302_CR9","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1007\/s10620-007-0196-4","volume":"53","author":"DH Sinn","year":"2008","unstructured":"Sinn DH, Song JH, Kim HJ, et al. Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome. Dig Dis Sci. 2008;53:2714\u20138.","journal-title":"Dig Dis Sci"},{"key":"302_CR10","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1111\/j.1365-2036.2011.04633.x","volume":"33","author":"S Guglielmetti","year":"2011","unstructured":"Guglielmetti S, Mora D, Gschwender M, Popp K. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life\u2014a double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2011;33:1123\u201332.","journal-title":"Aliment Pharmacol Ther"},{"key":"302_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3920\/BM2018.0008","volume":"10","author":"ZF Ma","year":"2019","unstructured":"Ma ZF, Yusof N, Hamid N, et al. Bifidobacterium infantis M-63 improves mental health in victims with irritable bowel syndrome developed after a major flood disaster. Benef Microbes. 2019;10:111\u201320.","journal-title":"Benef Microbes"},{"key":"302_CR12","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.3389\/fmicb.2018.01600","volume":"9","author":"X Zhuang","year":"2018","unstructured":"Zhuang X, Tian Z, Li L, Zeng Z, Chen M, Xiong L. Fecal microbiota alterations associated with diarrhea-predominant irritable bowel syndrome. Front Microbiol. 2018;9:1600.","journal-title":"Front Microbiol"},{"key":"302_CR13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12876-020-01336-6","volume":"20","author":"X Zhuang","year":"2020","unstructured":"Zhuang X, Tian Z, Luo M, Xiong L. Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome. BMC Gastroenterol. 2020;20:187.","journal-title":"BMC Gastroenterol"},{"key":"302_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.genhosppsych.2020.11.010","volume":"68","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Bi YX, Chen J, et al. Association of Peroxiredoxin 1 and brain-derived neurotrophic factor serum levels with depression and anxiety symptoms in patients with irritable bowel syndrome. Gen Hosp Psychiatry. 2021;68:59\u201364.","journal-title":"Gen Hosp Psychiatry"},{"key":"302_CR15","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/nbt.2676","volume":"31","author":"MG Langille","year":"2013","unstructured":"Langille MG, Zaneveld J, Caporaso JG, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol. 2013;31:814\u201321.","journal-title":"Nat Biotechnol"},{"key":"302_CR16","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1053\/j.gastro.2020.10.058","volume":"160","author":"R Mars","year":"2021","unstructured":"Mars R, Frith M, Kashyap PC. Functional gastrointestinal disorders and the microbiome\u2014what is the best strategy for moving microbiome-based therapies for functional gastrointestinal disorders into the clinic? Gastroenterology. 2021;160:538\u201355.","journal-title":"Gastroenterology"},{"key":"302_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1053\/j.gastro.2019.03.049","volume":"157","author":"R Pittayanon","year":"2019","unstructured":"Pittayanon R, Lau JT, Yuan Y, et al. Gut microbiota in patients with irritable bowel syndrome\u2014a systematic review. Gastroenterology. 2019;157:97\u2013108.","journal-title":"Gastroenterology"},{"key":"302_CR18","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.3748\/wjg.v22.i7.2219","volume":"22","author":"E Distrutti","year":"2016","unstructured":"Distrutti E, Monaldi L, Ricci P, Fiorucci S. Gut microbiota role in irritable bowel syndrome: new therapeutic strategies. World J Gastroenterol. 2016;22:2219\u201341.","journal-title":"World J Gastroenterol"},{"key":"302_CR19","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1080\/03007995.2017.1322571","volume":"33","author":"AP Allen","year":"2017","unstructured":"Allen AP, Clarke G, Cryan JF, Quigley E, Dinan TG. Bifidobacterium infantis 35624 and other probiotics in the management of irritable bowel syndrome. Strain specificity, symptoms, and mechanisms. Curr Med Res Opin. 2017;33:1349\u201351.","journal-title":"Curr Med Res Opin"},{"key":"302_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-230X-9-15","volume":"9","author":"N Hoveyda","year":"2009","unstructured":"Hoveyda N, Heneghan C, Mahtani KR, Perera R, Roberts N, Glasziou P. A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol. 2009;9:15.","journal-title":"BMC Gastroenterol"},{"key":"302_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/19490976.2018.1479625","volume":"10","author":"X Han","year":"2019","unstructured":"Han X, Lee A, Huang S, Gao J, Spence JR, Owyang C. Lactobacillus rhamnosus GG prevents epithelial barrier dysfunction induced by interferon-gamma and fecal supernatants from irritable bowel syndrome patients in human intestinal enteroids and colonoids. Gut Microbes. 2019;10:59\u201376.","journal-title":"Gut Microbes"},{"key":"302_CR22","doi-asserted-by":"publisher","first-page":"1782156","DOI":"10.1080\/19490976.2020.1782156","volume":"12","author":"C Zhou","year":"2020","unstructured":"Zhou C, Fang X, Xu J, et al. Bifidobacterium longum alleviates irritable bowel syndrome-related visceral hypersensitivity and microbiota dysbiosis via Paneth cell regulation. Gut Microbes. 2020;12:1782156.","journal-title":"Gut Microbes"},{"key":"302_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1365-2982.2010.01620.x","volume":"23","author":"KM Neufeld","year":"2011","unstructured":"Neufeld KM, Kang N, Bienenstock J, Foster JA. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil. 2011;23:255\u201364, e119.","journal-title":"Neurogastroenterol Motil"},{"key":"302_CR24","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.neuroscience.2010.08.005","volume":"170","author":"L Desbonnet","year":"2010","unstructured":"Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience. 2010;170:1179\u201388.","journal-title":"Neuroscience"},{"key":"302_CR25","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.biopsych.2013.05.001","volume":"74","author":"TG Dinan","year":"2013","unstructured":"Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biol Psychiatry. 2013;74:720\u20136.","journal-title":"Biol Psychiatry"},{"key":"302_CR26","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ijfoodmicro.2006.10.007","volume":"115","author":"G Paturi","year":"2007","unstructured":"Paturi G, Phillips M, Jones M, Kailasapathy K. Immune enhancing effects of Lactobacillus acidophilus LAFTI L10 and Lactobacillus paracasei LAFTI L26 in mice. Int J Food Microbiol. 2007;115:115\u20138.","journal-title":"Int J Food Microbiol"},{"key":"302_CR27","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/s41564-018-0272-x","volume":"3","author":"K Kasahara","year":"2018","unstructured":"Kasahara K, Krautkramer KA, Org E, et al. Interactions between Roseburia intestinalis and diet modulate atherogenesis in a murine model. Nat Microbiol. 2018;3:1461\u201371.","journal-title":"Nat Microbiol"},{"key":"302_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12866-017-1090-7","volume":"17","author":"MF Laursen","year":"2017","unstructured":"Laursen MF, Laursen RP, Larnkj\u00e6r A, Michaelsen KF, Bahl MI, Licht TR. Administration of two probiotic strains during early childhood does not affect the endogenous gut microbiota composition despite probiotic proliferation. BMC Microbiol. 2017;17:175.","journal-title":"BMC Microbiol"},{"key":"302_CR29","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1053\/j.gastro.2016.02.018","volume":"150","author":"S Vanner","year":"2016","unstructured":"Vanner S, Greenwood-Van MB, Mawe G, et al. Fundamentals of neurogastroenterology: basic science. Gastroenterology. 2016;150:1280.","journal-title":"Gastroenterology"},{"key":"302_CR30","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.3892\/mmr.2017.6226","volume":"15","author":"P Yao","year":"2017","unstructured":"Yao P, Tan F, Gao H, Wang L, Yang T, Cheng Y. Effects of probiotics on Toll-like receptor expression in ulcerative colitis rats induced by 2,4,6-trinitro-benzene sulfonic acid. Mol Med Rep. 2017;15:1973\u201380.","journal-title":"Mol Med Rep"},{"key":"302_CR31","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1053\/j.gastro.2004.11.050","volume":"128","author":"L O'Mahony","year":"2005","unstructured":"O\u2019Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 2005;128:541\u201351.","journal-title":"Gastroenterology"},{"key":"302_CR32","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s10068-019-00717-2","volume":"29","author":"J Kim","year":"2020","unstructured":"Kim J, Cho K, Kim JS, et al. Probiotic treatment induced change of inflammation related metabolites in IBS-D patients\/double-blind, randomized, placebo-controlled trial. Food Sci Biotechnol. 2020;29:837\u201344.","journal-title":"Food Sci Biotechnol"},{"key":"302_CR33","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jff.2018.07.008","volume":"48","author":"M Wang","year":"2018","unstructured":"Wang M, Chen Y, Wang Y, et al. Beneficial changes of gut microbiota and metabolism in weaned rats with Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 supplementation. J Funct Foods. 2018;48:252\u201365.","journal-title":"J Funct Foods"}],"container-title":["Journal of Health, Population and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41043-022-00302-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41043-022-00302-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41043-022-00302-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T10:07:57Z","timestamp":1652695677000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhpn.biomedcentral.com\/articles\/10.1186\/s41043-022-00302-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,16]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["302"],"URL":"https:\/\/doi.org\/10.1186\/s41043-022-00302-0","relation":{},"ISSN":["2072-1315"],"issn-type":[{"value":"2072-1315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,16]]},"assertion":[{"value":"13 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was approved by the Medical Ethics Committee of the First Affiliated Hospital of Sun Yat-sen University, and all patients had signed informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}